Literature DB >> 25944529

Somatic mosaicism of a novel IKBKG mutation in a male patient with incontinentia pigmenti.

Sarah Hull1,2, Gavin Arno1,2, Penelope Thomson3, Stacey Mutch4, Andrew R Webster1,2, Harjeet Rai4, Virginia Hill3, Anthony T Moore1,2.   

Abstract

Incontinentia pigmenti (IP) is an X-linked, dominant genodermatosis usually fatal in utero in males. In rare circumstances, survival is possible due to abnormal karyotype or somatic mosaicism. In this report, the mechanism and significance of loss of detectable mutation in peripheral blood leukocytes of a somatic mosaic male is discussed and an alternative approach to achieving molecular diagnosis presented. A male patient is reported, who initially presented at 2 days of age with a rash and seizure. Clinical assessment and histology of a skin biopsy were consistent with a diagnosis of IP. He was subsequently found to have bilateral retinal detachments. Screening for the common deletion in IKBKG was negative. A novel nonsense variant, c.937C>T (p.Gln313*) in IKBKG was identified at an approximate level of 15% in a blood sample taken at 10 days of age, but was undetectable in a sample taken at 3 years most likely due to selective apoptosis of mutant cells. Samples taken from the patient when he was 5-6 years of age identified the mutation at a low level in hair root and urine but not in blood or buccal cells. The detection of the mutation in cells derived from all germ layers indicates a de novo event at an early stage of embryogenesis. This is the first report of a nonsense mutation in a male IP patient.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  apoptosis; incontinentia pigmenti; somatic mosaicism

Mesh:

Substances:

Year:  2015        PMID: 25944529     DOI: 10.1002/ajmg.a.37004

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  The Incontinentia Pigmenti Genetic Biobank: study design and cohort profile to facilitate research into a rare disease worldwide.

Authors:  Francesca Fusco; Valeria Valente; Dario Fergola; Alessandra Pescatore; Maria Brigida Lioi; Matilde Valeria Ursini
Journal:  Eur J Hum Genet       Date:  2019-06-23       Impact factor: 4.246

2.  Clinical utility gene card: for incontinentia pigmenti.

Authors:  Francesca Fusco; Alessandra Pescatore; Julie Steffann; Jean-Paul Bonnefont; Judite De Oliveira; Maria Brigida Lioi; Matilde Valeria Ursini
Journal:  Eur J Hum Genet       Date:  2019-07-09       Impact factor: 4.246

3.  Absence of an osteopetrosis phenotype in IKBKG (NEMO) mutation-positive women: A case-control study.

Authors:  Morten Frost; Michaela Tencerova; Christina M Andreasen; Thomas L Andersen; Charlotte Ejersted; Dea Svaneby; Weimin Qui; Moustapha Kassem; Allahdad Zarei; William H McAlister; Deborah J Veis; Michael P Whyte; Anja L Frederiksen
Journal:  Bone       Date:  2019-01-16       Impact factor: 4.398

4.  NEMO Gene Mutations in Two Chinese Females with Incontinentia Pigmenti.

Authors:  Jingjing Jiang; Junjie Zeng; Qi He; Jiao Yang; Shenglan Wang; Zhengzhong Zhang
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-05-05

Review 5.  Human Genetic Diseases Linked to the Absence of NEMO: An Obligatory Somatic Mosaic Disorder in Male.

Authors:  Alessandra Pescatore; Ezia Spinosa; Carmela Casale; Maria Brigida Lioi; Matilde Valeria Ursini; Francesca Fusco
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 6.  Systemic and ocular manifestations of a patient with mosaic ARID1A-associated Coffin-Siris syndrome and review of select mosaic conditions with ophthalmic manifestations.

Authors:  Virginia Miraldi Utz; Diana S Brightman; Monica A Sandoval; Robert B Hufnagel; Howard M Saal
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-09-05       Impact factor: 3.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.